Search
-
Discover the variety of support services we offer to help children with pediatric blood disorders and their families at Memorial Sloan Kettering.
… At MSK Kids, we understand how overwhelming the diagnosis of a blood or immune disorder in a child can be for your whole family. Our team members are skilled in identifying and addressing the symptoms and possible side effects of treatment , including their social and psychological impact on your child
-
Video
Watch our postdocs face off against MSK faculty in a game of Charades.
… Watch our postdocs face off against MSK faculty in a game of Charades.
-
Technology Development
… SK2011-017 Summary of Invention Scientific figure Over 60% of melanoma tumors harbor activating mutations in the BRAF oncogene and patients with such tumors are suitable candidates for therapeutic intervention with RAF inhibitors such as Zelboraf. Upwards of 80% of patients treated with RAF inhibitors
-
Video
Cell biologist Philipp Niethammer investigates how white blood cells can detect a wound site by looking at the translucent tail fins of zebrafish.
… Cell biologist Philipp Niethammer investigates how white blood cells can detect a wound site by looking at the translucent tail fins of zebrafish.
-
The Craig Thompson Lab
… Job Title Senior Research Technician Email [email protected] Lab Phone 646-888-3285
-
Our Research Impact
Zvi Fuks, MD, is an emeritus member of Memorial Sloan Kettering. A renowned radiation oncologist, he held the Alfred P. Sloan Chair in Radiation Oncology, was Chair of the Department of Radiation Oncology, and was a member of the Molecular Pharmacology Program in the Sloan Kettering Institute.
… Job Title Emeritus Zvi Fuks, MD, is an emeritus member of Memorial Sloan Kettering. A renowned radiation oncologist, he held the Alfred P. Sloan Chair in Radiation Oncology, was Chair of the Department of Radiation Oncology, and was a member of the Molecular Pharmacology Program in the Sloan Kettering
-
News
Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.
… Friday, July 11, 2014 Summary Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it. The word “transformation” perfectly characterizes and captures the past year at Memorial Sloan Kettering. Indeed, it’s the word we
-
Genomics, Risk, and Health Decision-Making Laboratory
… Job Title Postdoctoral Research Scholar Giulia is a postdoctoral research fellow in the Genomics, Risk, and Health Decision-Making Laboratory. She is a clinical psychologist and CBT psychotherapist and received her PhD in System Medicine from the University of Milan and the European Institute of Oncology
-
Browse special events for MSK postdocs.
… Memorial Sloan Kettering sponsors special events throughout the year to help postdocs develop their professional skills — and to celebrate their accomplishments. For details about upcoming talks and lectures open to the entire scientific community, view our events calendar. Postdoc Slam Modeled after
-
News
Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change.
… Thursday, January 27, 2022 Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change. Dave Linn and Jennifer Goodman Linn used their experience with